Literature DB >> 28435410

Proton Pump Inhibitor-Responsive Esophageal Eosinophilia.

Evan S Dellon1.   

Abstract

Entities:  

Year:  2014        PMID： 28435410      PMCID： PMC5395715     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN： 1554-7914


× No keyword cloud information.
  13 in total

1.  Results of ambulatory pH monitoring do not reliably predict response to therapy in patients with eosinophilic oesophagitis.

Authors:  D L Francis; A Foxx-Orenstein; A S Arora; T C Smyrk; K Jensen; S L Nord; J A Alexander; Y Romero; D A Katzka
Journal:  Aliment Pharmacol Ther       Date:  2011-11-24       Impact factor: 8.171

2.  Proton pump inhibitor-responsive oesophageal eosinophilia correlates with downregulation of eotaxin-3 and Th2 cytokines overexpression.

Authors:  J Molina-Infante; M D Rivas; M Hernandez-Alonso; G Vinagre-Rodríguez; J M Mateos-Rodríguez; C Dueñas-Sadornil; B Perez-Gallardo; L Ferrando-Lamana; N Fernandez-Gonzalez; R Bañares; J Zamorano
Journal:  Aliment Pharmacol Ther       Date:  2014-08-11       Impact factor: 8.171

3.  Transient PPI responsive esophageal eosinophilia may be a clinical sub-phenotype of pediatric eosinophilic esophagitis.

Authors:  Ranjan Dohil; Robert O Newbury; Seema Aceves
Journal:  Dig Dis Sci       Date:  2011-12-02       Impact factor: 3.199

4.  Transcriptome analysis of proton pump inhibitor-responsive esophageal eosinophilia reveals proton pump inhibitor-reversible allergic inflammation.

Authors:  Ting Wen; Evan S Dellon; Fouad J Moawad; Glenn T Furuta; Seema S Aceves; Marc E Rothenberg
Journal:  J Allergy Clin Immunol       Date:  2014-10-19       Impact factor: 10.793

Review 5.  Eosinophilic esophagitis: updated consensus recommendations for children and adults.

Authors:  Chris A Liacouras; Glenn T Furuta; Ikuo Hirano; Dan Atkins; Stephen E Attwood; Peter A Bonis; A Wesley Burks; Mirna Chehade; Margaret H Collins; Evan S Dellon; Ranjan Dohil; Gary W Falk; Nirmala Gonsalves; Sandeep K Gupta; David A Katzka; Alfredo J Lucendo; Jonathan E Markowitz; Richard J Noel; Robert D Odze; Philip E Putnam; Joel E Richter; Yvonne Romero; Eduardo Ruchelli; Hugh A Sampson; Alain Schoepfer; Nicholas J Shaheen; Scott H Sicherer; Stuart Spechler; Jonathan M Spergel; Alex Straumann; Barry K Wershil; Marc E Rothenberg; Seema S Aceves
Journal:  J Allergy Clin Immunol       Date:  2011-04-07       Impact factor: 10.793

Review 6.  Thoughts on the complex relationship between gastroesophageal reflux disease and eosinophilic esophagitis.

Authors:  Stuart Jon Spechler; Robert M Genta; Rhonda F Souza
Journal:  Am J Gastroenterol       Date:  2007-06       Impact factor: 10.864

7.  ACG clinical guideline: Evidenced based approach to the diagnosis and management of esophageal eosinophilia and eosinophilic esophagitis (EoE).

Authors:  Evan S Dellon; Nirmala Gonsalves; Ikuo Hirano; Glenn T Furuta; Chris A Liacouras; David A Katzka
Journal:  Am J Gastroenterol       Date:  2013-04-09       Impact factor: 10.864

8.  Clinical and endoscopic characteristics do not reliably differentiate PPI-responsive esophageal eosinophilia and eosinophilic esophagitis in patients undergoing upper endoscopy: a prospective cohort study.

Authors:  Evan S Dellon; Olga Speck; Kimberly Woodward; Jessica H Gebhart; Ryan D Madanick; Sidney Levinson; Karen J Fritchie; John T Woosley; Nicholas J Shaheen
Journal:  Am J Gastroenterol       Date:  2013-10-22       Impact factor: 10.864

9.  Omeprazole blocks eotaxin-3 expression by oesophageal squamous cells from patients with eosinophilic oesophagitis and GORD.

Authors:  Edaire Cheng; Xi Zhang; Xiaofang Huo; Chunhua Yu; Qiuyang Zhang; David H Wang; Stuart Jon Spechler; Rhonda F Souza
Journal:  Gut       Date:  2012-05-12       Impact factor: 23.059

Review 10.  Proton-pump inhibitor-responsive esophageal eosinophilia.

Authors:  Javier Molina-Infante; David A Katzka
Journal:  Curr Opin Gastroenterol       Date:  2014-07       Impact factor: 3.287
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.